Dr. Thomas Kaley, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Brain Tumor
Thomas Kaley, MD has run 10 trials for Brain Tumor. Some of their research focus areas include:
Brain Cancer
Thomas Kaley, MD has run 5 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Clinical Trials Thomas Kaley, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Triple Therapy
for Brain Cancer
This study will test the safety and effectiveness of a combination of pembrolizumab, olaparib, and temozolomide to see how well these drugs work when given together in people with a glioma that either did not respond to previous treatment or came back after treatment.
Recruiting
1 award
Phase 2
30 criteria
More about Thomas Kaley, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Thomas Kaley, MD has experience with
- Abemaciclib
- Pembrolizumab
- Temozolomide
- Optune (NovoTTF-100A)
- AB-218
- MRI Perfusion
Breakdown of trials Thomas Kaley, MD has run
Brain Tumor
Brain Cancer
Glioblastoma
Meningioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Kaley, MD specialize in?
Thomas Kaley, MD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are Stage III.
Is Thomas Kaley, MD currently recruiting for clinical trials?
Yes, Thomas Kaley, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Thomas Kaley, MD has studied deeply?
Yes, Thomas Kaley, MD has studied treatments such as Abemaciclib, Pembrolizumab, Temozolomide.
What is the best way to schedule an appointment with Thomas Kaley, MD?
Apply for one of the trials that Thomas Kaley, MD is conducting.
What is the office address of Thomas Kaley, MD?
The office of Thomas Kaley, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.